(Q71973626)

English

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction

scientific article published on 01 May 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

phase II clinical trial

1 reference

based on heuristic

inferred from title

malignant pleural mesothelioma

1 reference

based on heuristic

inferred from title

immunologic adjuvant

1 reference

based on heuristic

inferred from title

author name string

H W Pass

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

B K Temeck

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

K Kranda

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

S M Steinberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

H I Pass

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 May 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

214-220

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

https://scigraph.springernature.com/pub.10.1007/bf02307026

0 references

Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology of asbestos-related tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II evaluation of recombinant interferon-beta (IFN-beta ser) in patients with diffuse mesothelioma: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon and cis-DDP: combination chemotherapy for P388 leukemia in CDF1 mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant pleural mesothelioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced inhibition of anticancer drugs by human recombinant gamma-interferon for human renal cell carcinoma in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation of cytotoxicity of chemotherapy by human alpha-interferons in human non-small cell lung cancer xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of the combination of alpha-2 interferon and cisplatinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occupational exposure to asbestos: population at risk and projected mortality--1980-2030

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro studies on potentiation of cytotoxic effects of anticancer drugs by interferon on a human neoplastic cell line (HeLa)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7641017

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02307026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7641017%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71973626&oldid=1831888772"